These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 35382979)

  • 41. The potential role of HLA-G polymorphism in maternal tolerance to the developing fetus.
    Agrawal S; Pandey MK
    J Hematother Stem Cell Res; 2003 Dec; 12(6):749-56. PubMed ID: 14977483
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Human ILT2 receptor associates with murine MHC class I molecules in vivo and impairs T cell function.
    Liang S; Zhang W; Horuzsko A
    Eur J Immunol; 2006 Sep; 36(9):2457-71. PubMed ID: 16897816
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Immunology of pregnancy].
    Kayem G; Batteux F
    Presse Med; 2008 Nov; 37(11):1612-9. PubMed ID: 18768289
    [No Abstract]   [Full Text] [Related]  

  • 44. HLA-G modulates immune responses by diverse receptor interactions.
    Hofmeister V; Weiss EH
    Semin Cancer Biol; 2003 Oct; 13(5):317-23. PubMed ID: 14708711
    [TBL] [Abstract][Full Text] [Related]  

  • 45. HLA-G-treated tolerogenic dendritic cells induce tolerogenic potential by increasing expression of B7-1 (CD80) molecules.
    Smith M; Bittner JG; White S; Smith D; Horuzsko A
    Transplant Proc; 2008 Jun; 40(5):1598-603. PubMed ID: 18589158
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Primary cutaneous CD8+ and CD56+ T-cell lymphomas express HLA-G and killer-cell inhibitory ligand, ILT2.
    Urosevic M; Kamarashev J; Burg G; Dummer R
    Blood; 2004 Mar; 103(5):1796-8. PubMed ID: 14592815
    [TBL] [Abstract][Full Text] [Related]  

  • 47. HLA-G mediates protection from natural killer cytolysis: implications in immune tolerance.
    Carosella ED; Khalil-Daher I; Dausset J; Rouas-Freiss N
    Transplant Proc; 1999; 31(1-2):1192-3. PubMed ID: 10083531
    [No Abstract]   [Full Text] [Related]  

  • 48. HLA-G and NK receptor are expressed in psoriatic skin: a possible pathway for regulating infiltrating T cells?
    Aractingi S; Briand N; Le Danff C; Viguier M; Bachelez H; Michel L; Dubertret L; Carosella ED
    Am J Pathol; 2001 Jul; 159(1):71-7. PubMed ID: 11438456
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Immune modulation of HLA-G dimer in maternal-fetal interface.
    Kuroki K; Maenaka K
    Eur J Immunol; 2007 Jul; 37(7):1727-9. PubMed ID: 17587197
    [TBL] [Abstract][Full Text] [Related]  

  • 50. MICA triggering signal for NK cell tumor lysis is counteracted by HLA-G1-mediated inhibitory signal.
    Menier C; Riteau B; Carosella ED; Rouas-Freiss N
    Int J Cancer; 2002 Jul; 100(1):63-70. PubMed ID: 12115588
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A simple method for identifying bone marrow mesenchymal stromal cells with a high immunosuppressive potential.
    Rizzo R; Lanzoni G; Stignani M; Campioni D; Alviano F; Ricci F; Tazzari PL; Melchiorri L; Scalinci SZ; Cuneo A; Bonsi L; Lanza F; Bagnara GP; Baricordi OR
    Cytotherapy; 2011 May; 13(5):523-7. PubMed ID: 21171826
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [HLA-G: from feto-maternal tolerance to organ grafting].
    Carosella ED
    Bull Mem Acad R Med Belg; 2009; 164(3-4):87-99; discussion 99-101. PubMed ID: 20120086
    [TBL] [Abstract][Full Text] [Related]  

  • 53. HLA-G expression in cancers: potential role in diagnosis, prognosis and therapy.
    Yan WH
    Endocr Metab Immune Disord Drug Targets; 2011 Mar; 11(1):76-89. PubMed ID: 21348818
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A novel mechanism of soluble HLA-G mediated immune modulation: downregulation of T cell chemokine receptor expression and impairment of chemotaxis.
    Morandi F; Ferretti E; Bocca P; Prigione I; Raffaghello L; Pistoia V
    PLoS One; 2010 Jul; 5(7):e11763. PubMed ID: 20668702
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Tumor infiltrating and peripheral CD4
    Jacquier A; Lambert T; Delattre JF; Djouadou M; Vérine J; Dumont C; Desgrandchamps F; Carosella ED; LeMaoult J; Rouas-Freiss N
    Cancer Lett; 2021 Oct; 519():105-116. PubMed ID: 34186161
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Stranger in a strange land.
    Hunt JS
    Immunol Rev; 2006 Oct; 213():36-47. PubMed ID: 16972895
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Soluble HLA-G inhibits myeloid dendritic cell function in HIV-1 infection by interacting with leukocyte immunoglobulin-like receptor B2.
    Huang J; Burke P; Yang Y; Seiss K; Beamon J; Cung T; Toth I; Pereyra F; Lichterfeld M; Yu XG
    J Virol; 2010 Oct; 84(20):10784-91. PubMed ID: 20702625
    [TBL] [Abstract][Full Text] [Related]  

  • 58. CD8(+)HLA-G(+) regulatory T cells are expanded in HIV-1-infected patients.
    Lozano JM; González R; Luque J; Frias M; Rivero A; Peña J
    Viral Immunol; 2009 Dec; 22(6):463-5. PubMed ID: 19951184
    [TBL] [Abstract][Full Text] [Related]  

  • 59. HLA-G molecule.
    Kamishikiryo J; Maenaka K
    Curr Pharm Des; 2009; 15(28):3318-24. PubMed ID: 19860681
    [TBL] [Abstract][Full Text] [Related]  

  • 60. HLA-G truncated isoforms can substitute for HLA-G1 in fetal survival.
    Menier C; Riteau B; Dausset J; Carosella ED; Rouas-Freiss N
    Hum Immunol; 2000 Nov; 61(11):1118-25. PubMed ID: 11137216
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.